Thomas Inglesby, MD, was appointed Chief Executive Officer and Director of the Center for Biosecurity of UPMC in November 2009. Prior to this appointment, Dr. Inglesby was the Chief Operating Officer and Deputy Director of the Center for Biosecurity. He is an Associate Professor of Medicine and Public Health at the University of Pittsburgh Schools of Medicine and Public Health. 

Dr. Inglesby has been with the Center since its inception. He was one of its founding members in 1998, and he has continued to play a leadership role for more than 10 years. An infectious disease physician by training, he early on became interested in the issues surrounding biosecurity and was tapped to join the newly established Johns Hopkins Center for Civilian Biodefense Strategies, where he later served as Deputy Director from 2001 to 2003, when the Hopkins Center staff joined UPMC to found the Center for Biosecurity.

Over the years, Dr. Inglesby has worked to raise awareness among leaders in government and academia as well as the public of the threats posed by biological weapons and major infectious disease epidemics and the actions needed to diminish these threats. In June 2001, the Center presented Dark Winter, an exercise that brought attention to the consequences of a bioterrorist attack using smallpox. Dr. Inglesby was a principal author of this widely publicized scenario and of the 2005 Atlantic Storm exercise, which explored the international implications of a smallpox attack.

Dr. Inglesby has served in advisory capacities for a number of government and scientific organizations and academia on issues related to biosecurity. He has provided briefings for officials in several presidential administrations, members of the U.S. Congress and their staff. Dr. Inglesby has also served on committees of the Defense Science Board and the National Research Council of the National Academies of Sciences, and has served in advisory roles to the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the U.S. Departments of Health and Human Services and Homeland Security, the Defense Advanced Research Projects Agency (DARPA), the Defense Intelligence Agency (DIA), and the Director of National Intelligence (DNI).

Dr. Inglesby has authored or co-authored more than 50 articles on a range of biosecurity issues, including U.S. biosecurity strategy, pandemic influenza, anthrax, smallpox, plague, public health and hospital preparedness, medical countermeasures, and scientific research strategy. He is a principal editor of the Journal of the American Medical Association (JAMA) book, Bioterrorism: Guidelines for Medical and Public Health Management.

In 2003, Dr. Inglesby became coeditor-in-chief of the peer-reviewed journal, Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. The journal is read in more than 90 countries and is sent quarterly to leaders in government agencies, the Congress, and the White House, as well as to members of the press.

Dr. Inglesby received a BA from Georgetown University and an MD from the Columbia University College of Physicians and Surgeons. He completed his Internal Medicine Residency and Infectious Diseases Fellowship training at the Johns Hopkins University School of Medicine and served as Assistant Chief of Service in the Johns Hopkins Department of Medicine in 1996-97. He was a faculty member of the Johns Hopkins School of Medicine from 1999 to 2003.